In B16-F10 melanoma cells, treatment of nomilin exhibited a down-regulated Bcl-2, cyclin D1 expression, and up-regulated p53, Bax, caspase-9, caspase-3, p21, and p27 gene expression. Here, BCL2 is linked to melanoma.